Alnylam Pharmaceuticals, Inc. (ALNY) Stock Forecast
ALNY analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.33 / 5 from 30 analysts
- Price target
- $368.71 average of analyst targets
- Upside to target
- +59.0% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $1.68
- 52-week range
- $205.48 – $491.22
ALNY analyst ratings
30 analystsNumber of analysts at each rating.
ALNY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ALNY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.26 | $1.87 | $3.12 | $2.90 | −22.0% | 12 |
| Current fiscal year (2026) | $8.94 | $8.22 | $10.38 | $5.08 | +75.9% | 12 |
| Next fiscal year (2027) | $12.48 | $8.72 | $17.71 | $8.94 | +39.6% | 12 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ALNY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.43B | $1.34B | $1.50B | +14.6% | 21 |
| Current fiscal year (2026) | $5.48B | $5.28B | $5.77B | +47.5% | 27 |
| Next fiscal year (2027) | $6.90B | $6.14B | $7.95B | +26.0% | 27 |
ALNY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ALNY revenue: reported and forecast
ALNY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.41 | $2.32 | $2.32 | $2.28 | $2.26 | −6.0% | 0 up · 2 down |
| Current fiscal year (2026) | $9.42 | $8.92 | $8.85 | $8.83 | $8.94 | −5.2% | 0 up · 2 down |
| Next fiscal year (2027) | $13.40 | $12.59 | $12.47 | $12.42 | $12.48 | −6.9% | 0 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ALNY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ALNY beat in 9 of 12.
What analysts expect from ALNY
30 analysts cover Alnylam; their consensus rating is buy (4.33 on a 1–5 scale, where 5 is a strong buy). The average price target is $368.71, 59.0% above the latest close of $231.83. Analysts expect earnings of $8.94 per share for 2026, +75.9% from a year earlier. For 2027 the average estimate is $12.48 per share on revenue of $6.9 billion. Alnylam beat the EPS estimate in 9 of the last 12 quarters.
Related: ALNY income statement, ALNY key metrics, ALNY chart. See the ALNY stock overview for the latest quote and news.
ALNY forecast FAQ
What is Alnylam's price target?
The average analyst price target for Alnylam is $368.71, 59.0% above the latest close of $231.83.
Is Alnylam a buy, hold or sell?
Of 30 analysts covering Alnylam, 17 rate it a strong buy, 6 a buy, 7 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Alnylam's EPS forecast?
Analysts forecast $8.94 per share for 2026 (range $8.22 to $10.38); for 2027 the estimate is $12.48.
What is Alnylam's revenue forecast?
The average revenue estimate for 2026 is $5.5 billion, growth of 47.5%; for 2027 it is $6.9 billion.
When does Alnylam report earnings?
Alnylam is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 before the market opens; the EPS estimate is $1.68.
Does Alnylam usually beat earnings estimates?
Alnylam reported EPS at or above the analyst estimate in 9 of the last 12 quarters.